Clinical Trial Update: S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial S9809 comparing ciprofloxacin with cephalexin for bladder cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Cephalexin (Cephalexin)
• Ciprofloxacin (Ciprofloxacin hydrochloride)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Bladder Cancer | Phase 3 | Status: TERMINATED